Effect of PPCI on Diastolic Function & Levels of Galactin-3 in Patients With STEMI
1 other identifier
observational
80
1 country
1
Brief Summary
- 2D Echocardiography with color Doppler assessment: It will be done within 24 h after PPCI
- Peripheral blood samples were obtained within 48 hours after acute MI, and the serum will be frozen at -70°C until tested for Galactin-3 level.
- Follow up 2D Doppler echocardiography: will be repeated at 40 days of the event.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2021
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedFirst Posted
Study publicly available on registry
November 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2023
CompletedNovember 4, 2021
October 1, 2021
1.2 years
October 25, 2021
October 25, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Acute effect of PPCI in STEMI patients on diastolic function and Galactin-3 level
Determine the acute effect of PPCI in STEMI patients on the level of Galectin 3 and diastolic function within 48 hrs of the event.
48 hrs
Secondary Outcomes (1)
Correlation to patients' outcomes especially in those with initial high serum Galactin-3
40 days
Study Arms (1)
STEMI patients who underwent PPCI
2D Echocardiography with color Doppler assessment will be done within 24 h after PPCI Biochemical measurements: Peripheral blood samples were obtained within 48 hours after acute MI, and the serum will be frozen at -70°C until tested for Galactin-3 level. Follow up 2D Doppler echocardiography will be repeated at 40 days of the event.
Interventions
* Measurements will be 1. Pulsed wave (PW) Doppler 2. E (early diastolic)/A (late diastolic) - Using PW Doppler 3. IVRT (isovolumic relaxation time) 4. Deceleration time (DT) - from the peak of E wave to baseline. 5. E/e'- PW tissue Doppler imaging (TDI) 6. Left atrial volume and left atrial volume index (LAVI) * Peripheral blood samples will be obtained within 48 hours after acute MI, and the serum will be frozen at -70°C until tested for Galactin-3 level.
Eligibility Criteria
All patients with age \> 18 years who will present in the emergency department within 12 h (hrs) of the onset of ischemic chest pain \& fulfill the diagnostic criteria of acute STEMI as defined by the universal definition of Myocardial Infarction (9) and are eligible for primary PCI will be included in this study.
You may qualify if:
- All patients of sample size admitted to the cardiology department of Assiut university hospital with:
- Acute typical chest pain
- Positive cardiac enzymes.
- ECG shows ST-segment elevation MI
- Documented occlusion of CA then treatment by PPCI
You may not qualify if:
- \. Patients with well-known factors of left ventricular diastolic dysfunctions, including high blood pressure (over 140/90 mmHg), hypertrophic cardiomyopathy, left ventricular hypertrophy, bundle branch block, ventricular fibrillation, ventricular arrhythmia, severe valvular disease, complete heart block, and previous CABG.
- \. Patients with the end-stage renal disease usually have markedly increased galactin-3 levels 3. Prior use of thrombolytic agents 4. Refusal of PPCI due to social or religious concerns 5. ST elevation on ECG without obvious coronary artery diseases such as acute myocarditis, early repolarization, or Takotsubo cardiomyopathy 6. Atrial fibrillation at the time of echocardiography examination.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine Assiut University
Asyut, Asyut Governorate, Egypt
Related Publications (2)
Karaye KM, Sani MU. Factors associated with poor prognosis among patients admitted with heart failure in a Nigerian tertiary medical centre: a cross-sectional study. BMC Cardiovasc Disord. 2008 Jul 22;8:16. doi: 10.1186/1471-2261-8-16.
PMID: 18644161BACKGROUNDMcManus DD, Chinali M, Saczynski JS, Gore JM, Yarzebski J, Spencer FA, Lessard D, Goldberg RJ. 30-year trends in heart failure in patients hospitalized with acute myocardial infarction. Am J Cardiol. 2011 Feb 1;107(3):353-9. doi: 10.1016/j.amjcard.2010.09.026.
PMID: 21256998BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hatem Helmy, Professor
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Mariam Bady Adly Hanna
Study Record Dates
First Submitted
October 25, 2021
First Posted
November 4, 2021
Study Start
November 1, 2021
Primary Completion
January 1, 2023
Study Completion
May 1, 2023
Last Updated
November 4, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share